(2000). Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford)..
(2000). The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/1099-1557(200009/10)9:5<359::aid-pds507>3.0.co;2-e.
(2000). Use of oral corticosteroids and risk of fractures. J Bone Miner Res. http://doi.org/10.1359/jbmr.2000.15.6.993.
(2000). Use of oral corticosteroids in the United Kingdom. Qjm..
(2001). Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol..
(2007). Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kel249.
(2009). A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example. PLoS Med. http://doi.org/10.1371/journal.pmed.1000194.
(2009). The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database. J Hypertens. http://doi.org/10.1097/HJH.0b013e32832af68d.
(2010). Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD. Eur Respir J. http://doi.org/10.1183/09031936.00124209.